| Description |
1 online resource (xiii, 108 pages) : illustrations |
| Physical Medium |
polychrome |
| Description |
text file |
| Bibliography |
Includes bibliographical references (pages 91-93). |
| Contents |
Introduction -- Panel I: NCI and the cooperative groups -- Panel II: Payors -- Panel III: Interactions between industry, the FDA, and the publicly funded cancer clinical trials system -- Panel IV: Clinical trials investigators and patient advocates -- Closing remarks. |
| Summary |
"Clinical trials enable scientific discoveries to advance patient care, in addition to informing and guiding subsequent research. The National Cancer Institute's (NCI's) Clinical Trials Cooperative Group Program works to advance patient care and research. The Cooperative Group Program has been instrumental in establishing the standards for cancer patient care and clinical research methods. Despite broad participation in the program, financial strain and procedural burdens limit the ability of the Cooperative Group Program to undertake medical practice-changing clinical research. Thus, the Institute of Medicine's (IOM's) National Cancer Policy Forum and the American Society of Clinical Oncology held a workshop on March 21, 2011 to follow up on the 2010 IOM report, A National Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program, which made recommendations to strengthen the NCI Cooperative Group Program. In keeping with the established commitment to excellence Implementing a National Cancer Clinical Trials System for the 21st Century outlines how to improve the current system by incorporating innovative science and trial design into cancer clinical trials. It also examines the impact of increasing quality in regards to speed, efficiency, design, launch, and conduct, as well as improving prioritization, and incentivized participation."--Publisher's description. |
| Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
American Society of Clinical Oncology.
|
|
American Society of Clinical Oncology. |
|
American Society of Clinical Oncology. |
|
Cancer -- Treatment -- Government policy -- United States.
|
|
Cancer -- Treatment. |
|
Government policy. |
|
United States. |
|
Clinical trials -- Standards -- United States.
|
|
Clinical trials -- Standards. |
|
Clinical trials. |
|
Neoplasms -- therapy. |
|
Clinical Trials as Topic -- standards. |
|
Health Policy. |
|
Patient Care -- standards. |
|
United States. |
| Genre/Form |
Congress.
|
|
Electronic books.
|
|
Conference papers and proceedings.
|
|
Conference papers and proceedings.
|
| Added Author |
Mack, Alison.
|
|
Nass, Sharyl J.
|
|
National Cancer Policy Forum (U.S.)
|
|
American Society of Clinical Oncology.
|
|
Institute of Medicine (U.S.). Board on Health Care Services.
|
| Other Form: |
Print version: American Society of Clinical Oncology and Institute of Medicine Workshop (2011 : Washington, DC). Implementing a national cancer clinical trials system for the 21st century. Washington, D.C. : National Academies Press, ©2011 9780309212687 (OCoLC)747314133 |
| ISBN |
9780309212694 (electronic book) |
|
0309212693 (electronic book) |
|
1283311887 |
|
9781283311885 |
|
0309212685 |
|
9780309212687 |
|
